Todd Brantley, OD
Optometrist · Plano, TXNPI 1760595631
Payments from drug & device makers
Across 276 payments — averaging $47.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$4K
- Coopervision Inc.$4K
- Alcon$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$644
- Bausch & Lomb Americas Inc.$613
- Biotissue Holdings Inc.$396
- plus $2K from 20 others
What the payments were for
- Consulting fees$1,76514%
- Travel & lodging$1,72413%
- Food & beverage$9,34472%
- Entertainment$1271%
- Other$360%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 66 | $3,767 |
| Coopervision Inc. | 59 | $3,509 |
| Alcon | 61 | $2,038 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 15 | $644 |
| Bausch & Lomb Americas Inc. | 18 | $613 |
| Biotissue Holdings Inc. | 11 | $396 |
| Lumenis BE Inc | 1 | $337 |
| Optos, Inc. | 4 | $306 |
| LKC Technologies, Inc. | 2 | $284 |
| Maculogix, Inc. | 2 | $138 |
| ABB Con-cise Optical Group LLC | 3 | $135 |
| Sun Pharmaceutical Industries Inc. | 6 | $128 |
| Sanofi | 1 | $122 |
| AbbVie(2 entities) | 5 | $117 |
| Tarsus Pharmaceuticals, Inc. | 3 | $61 |
| Thea Pharma Inc. | 3 | $55 |
| Novartis | 3 | $51 |
| Dompe US, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $49 |
| Oyster Point Pharma, Inc. | 3 | $43 |
| Baxter Healthcare | 1 | $36 |
| Sight Sciences, Inc. | 1 | $34 |
| Glaukos Corporation | 1 | $32 |
| Synergeyes, Inc. | 1 | $22 |
| Heidelberg Engineering, Inc. | 1 | $18 |
| Lombart Brothers, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVI Contact Lens$1,724
- Acuvue$1,148
- TOTAL30$493
- INFUSE$364
- optilight$337
- PANORAMIC OPHTHALMOSCOPE$253
- OCT OPHTHALMOSCOPE$253
- DAILIES TOTAL1$253
- NFC-700$127
- AdaptDx$126
- ALDURAZYME$122
- FABRAZYME$122
- CERDELGA$122
- CEREZYME$122
- LUMIZYME$122
- BIOTRUE ONE DAY$114
- Multiple Brands Contact Lens$111
- MyDay Contact Lens$104
- Precision7$101
How this compares
$12,995 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 88 | $809 |
| Timolol Maleate | 36 | $809 |
| Prednisolone Acetate | 17 | $475 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Plano
- Christina ChangPlano$117K
- Tiffany HuynhHouston$3.2M
- Bridgitte LeeHouston$3M
- Bryan FrazierTyler$1.4M
- Derek CunninghamAustin$940K
- Wendy ChungKaty$900K
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
- Mina VanrachackSan Antonio$553K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.